Update: Pharmacologic Glycemic Management of Type 2 Diabetes
Diabetes Canada has published an updated guide to the Pharmacologic Glycemic Management of Type 2 Diabetes. The update is available in the October 2020 issue of the Canadian Journal of Diabetes.
This update includes the recognition of medications with evidence for:
- cardiovascular benefits (some in the absence of established CVD)
- reduced hospitalization for heart failure
- slowed progression of kidney disease
- evidence of weight loss or reduced weight gain
There is a User's Guide following a Question and Answer format in the same issue.
Update: Diabetes Canada Prof Conference Group Discount
Diabetes Canada is offering a group registration discount for their 2020 Professional Conference. The conference is being held virtually from Oct 28 to 30.
If 3 or more people register as a group, you will get a 20% discount. Details are available here.
Update: Medtronic Stand-Alone Guardian Connect rtCGM
Medtronic Canada is officially launching Guardian™ Connect Continuous Glucose Monitoring System (Guardian Connect System)! This is a stand-alone system that works with an iOS app and features Bluetooth connectivity, automatic CareLink™ uploads and customizable predictive glucose alerting with up to 60-minute advance notification preceding a hypo or hyperglycemic threshold.
As of August 24th, 2020, patients may order the Guardian Connect System through two channels: Visiting the Medtronic eShop, or Speaking directly to a representative by calling 1-800-284-4416 For more information, visit their website.